ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PAVM vs CTSO // 10Y YIELD & FRED MACRO BETA

PAVmed Inc. (NASDAQ) VS. Cytosorbents Corporation (NASDAQ) • 15-METRIC TALLY: PAVM 1 — CTSO 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PAVM VS. CTSO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PAVM CTSO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 71.50% -101.50 CTSO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -39.80% -20.20 CTSO /operating-margins <GO>
Net Profit Margin -60.00% -22.10% -37.90 CTSO /net-margins <GO>
Revenue Growth (YoY) -65.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 CTSO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 26.5 47.9 -21.33 CTSO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $15.8M $13.9M $1.9M PAVM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PAVM REV CTSO REV PAVM GROSS % CTSO GROSS % PAVM FCF CTSO FCF
FY 2025 $71.0K $37.1M -50.0% 71.5% -$5.2M -$12.5M
FY 2024 $3.0M $35.6M -50.0% 69.9% -$33.6M -$14.7M
FY 2023 $2.5M $0 — — -$52.0M -$21.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PAVM // BETA —
CTSO // BETA —